Revealing Activation Mechanism of Alk2 Kinase Mutations in Fibrodysplasia Ossificans Progressiva (FOP)

被引：0
|
作者：
Alsamarah, Abdelaziz [1 ]
Hao, Jijun [2 ]
Luo, Yun [1 ]
机构：
[1] Western Univ Hlth Sci, Pharmaceut Sci, Pomona, CA USA
[2] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA
来源：
BIOPHYSICAL JOURNAL | 2016年 / 110卷 / 03期
关键词：
D O I：
10.1016/j.bpj.2015.11.1146
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
1024-Pos
引用
收藏
页码：206A / 206A
页数：1
相关论文
共 50 条
  • [41] A potential case of fibrodysplasia ossificans progressiva (FOP) lacking any mutations in ACVR1
    Deffendall, Catherine
    Black, Margo
    Halpern, Jennifer
    Perrien, Daniel
    Dahir, Kathryn
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 15 - 16
  • [42] Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva
    Yamamoto, Hirofumi
    Sakai, Naoki
    Ohte, Satoshi
    Sato, Tomohiro
    Sekimata, Katsuhiko
    Matsumoto, Takehisa
    Nakamura, Kana
    Watanabe, Hisami
    Mishima-Tsumagari, Chiemi
    Tanaka, Akiko
    Hashizume, Yoshinobu
    Honma, Teruki
    Katagiri, Takenobu
    Miyazono, Kohei
    Tomoda, Hiroshi
    Shirouzu, Mikako
    Koyama, Hiroo
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 38
  • [43] Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva (FOP)
    Brennan, Tracy A.
    Lindborg, Carter M.
    Bergbauer, Christian R.
    Wang, Haitao
    Kaplan, Frederick S.
    Pignolo, Robert J.
    [J]. BONE, 2018, 109 : 259 - 266
  • [44] Assessment Tools of Physical and Functional Disability in Fibrodysplasia Ossificans Progressiva (FOP).
    Kaplan, Frederick S.
    Hsiao, Edward C.
    Baujat, Genevieve
    Di Rocco, Maja
    Brown, Matthew A.
    De Cunto, Carmen
    Keen, Richard
    Al Mukaddam, Mona
    Grogan, Donna R.
    Pignolo, Robert J.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S391 - S392
  • [45] BLU-782; a highly selective ALK2 inhibitor, designed specifically to target the cause of fibrodysplasia ossificans progressiva
    Davis, Alison
    Hodous, Brian
    Labranche, Timothy
    Sheets, Michael
    Brooijmans, Natasja
    Kim, Joseph
    Williams, Brett
    Kim, Sean
    Xu, Lan
    Vassiliadis, John
    Zhu, Julia
    Wang, Ruduan
    Stewart, Rachel
    Fleming, Paul
    Graul, Chris
    Greenblatt, Elliot
    Bouchard, Keith
    Kadambi, Vivek
    Guzi, Timothy
    Hunter, Jeffrey
    Lengauer, Christoph
    Dorsch, Marion
    Garner, Andrew
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 26 - 26
  • [46] Palovarotene Reduces New Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP)
    Kaplan, Frederick S.
    Hsiao, Edward C.
    Baujat, Genevieve
    Keen, Richard
    De Cunto, Carmen
    Di Rocco, Maja
    Brown, Matthew A.
    Al Mukaddam, Mona M.
    Grogan, Donna R.
    Pignolo, Robert J.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 420 - 420
  • [47] The Diagnostic Journey in Fibrodysplasia Ossificans Progressiva: Insights from the FOP Registry
    Sherman, L. Adam
    Cheung, Kin
    De Cunto, Carmen
    Kile, Sammi
    Pignolo, Robert
    Kaplan, Frederick
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 310 - 310
  • [48] Feline Fibrodysplasia Ossificans Progressiva-Like (FOP-Like)
    Elvira, A.
    [J]. CLINICA VETERINARIA DE PEQUENOS ANIMALES, 2010, 30 (01): : 15 - 22
  • [49] Diagnosis of Fibrodysplasia ossificans progressiva (FOP) prior to the onset of Heterotopic ossification
    Xu, M.
    Ganguly, A.
    Kallan, F. S.
    Shore, E. M.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S352 - S352
  • [50] Mutations in the BMP type I receptor ACVR1 in patients with fibrodysplasia ossificans progressiva (FOP).
    Shore, E. M.
    Xu, M.
    Connor, J. M.
    Kaplan, F. S.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S75 - S75
12345